Science Resources RSS Feeds
|
 |
 |
 |
| View Larger Image | Hypertril for Pulmonary Hypertension - Normalize blood pressure levels - Bio-Enhanced Extraction Technology | Health and Beautyby HP-Hypertril
| 1 New starting at: | $29.90 |
| |
|
|
FEATURES | - Get optimal benefits with new Bio-Enhanced Extraction technology!
- Bio-Enhanced Extraction (B.E.E.) is a revolutionary extraction technology, which is comprised of a 3-step process of extraction, isolation/purification and bio-enhancement using only those bioactive compounds of plants that have been determined to be the most beneficial for the body in each formula. This patent-pending process is responsible for the proven fast acting, targeted action and safety of each product.
- One bottle contains 45 Vegicaps
|
EDITORIAL REVIEWS |
Product Description
A number of studies have demonstrated that increased free radical activity plays an important role in all cases of high blood pressure, because increased free radicals cause cellular damage and inactivate nitric oxide. Nitric oxide, an important molecular regulator of blood pressure, helps control blood pressure by dilating blood vessels. Antioxidants, powerful free radical scavengers, may help restore activities of nitric oxide and help to control blood pressure. This is the main theoretical basis of HypertrilTM. In addition to antioxidant activities, Hypertril also provides essential nutrients to support blood pressure control and improve circulation.
In a study performed at the Institut de Cardiologie de Montreal, Canada, Hypertril demonstrated a significant reduction in MAP (Mean Arterial Pressure) and ventricular function. Amazingly, right ventricular weight/body weight ratio was also decreased. Hypertril treatment also significantly improved LVSP (Left Ventricular Systolic Pressure) and left ventricular relaxation as assessed by left ventricular end diastolic pressure (LVEDP) was also significantly reduced by Hypertril treatment. Hypertril reduction of LVEDP was associated with a decrease in lung weight/body weight ratio. Consistent with this latter result, right ventricular hypertrophy was also reduced with Hypertril therapy. Thus, Hypertril may be beneficial in the treatment of pulmonary hypertension via its therapeutic action on LVEDP. |
|
|
